0.00420.00% ( -0.001 )
Delay Closed: Oct 7, 17:16:00Current ValuationThe current P/E ratio is -2.06, within the reasonable range, cheaper than 42.27% of the time in the past 3 years, and the industry ranks 1/4, the industry Median -4.65.
-2.06xP/E
S$0.00Stock price
S$-0.00Earnings per share
-2.06xP/E
Stock priceS$0.00Earnings per shareS$-0.00
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -2.18x
- Typical range
- -2.92x–-1.58x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
01234
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x0.2x0.4x0.6x0.8x1x
| Name/Symbol | |||
|---|---|---|---|
8YYSGEFH | -18.19x | -- | S$55.47M |
569SGVicplas | -6.56x | -- | S$33.73M |
V8YSGQuantum Health | -4.65x | -- | S$12.59M |
584SGAJJ Medtech | -2.06x | -- | S$6.93M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
